Skip to main content

colesevelam (Cholestagel®)

 

Following non-submission

AWMSG advice

Status: Not endorsed (Statement of Advice)

Colesevelam (Cholestagel®) has not been endorsed for use within NHS Wales in combination with ezetimibe, with or without a statin, for the treatment of adult patients with primary hypercholesterolaemia, including patients with familial hypercholesterolaemia. The holder of the marketing authorisation is not in a position to progress a submission to AWMSG for the appraisal of colesevelam (Cholestagel®) for the above indication. As a result, AWMSG cannot provide advice to the Minister for Health and Social Services.

 Statement of Advice (SOA): colesevelam (Cholestagel) 668 (PDF, 48Kb)

Medicine details

Medicine name colesevelam (Cholestagel®)
Formulation 625 mg film-coated tablet
Reference number 668
Indication

In combination with ezetimibe, with or without a statin, for the treatment of adult patients with primary hypercholesterolaemia, including patients with familial hypercholesterolaemia

Company Genzyme Therapeutics
BNF chapter Cardiovascular system
Submission type Non-submission
Status Not endorsed (Statement of Advice)
Date of issue 11/08/2010
Follow AWTTC: